Journal Home
Search for

Volume 581, Issue 19, Pages 3681-3688 (31 July 2007)


View previous. 15 of 25 View next.

Chaperonopathies and chaperonotherapy

Edited by Robert Barouki

Alberto J.L. MacarioCorresponding Author Informationemail address, Everly Conway de Macarioemail address

Received 3 March 2007; received in revised form 5 April 2007; accepted 15 April 2007. published online 24 April 2007.

Abstract 

The study of molecular chaperones (genetics, structure, location, physiology, pathology, and therapeutics) has developed into a science with specific objectives, methods, and hypotheses, a discipline we called chaperonology. Subdisciplines of chaperonology include the study of pathological chaperones (chaperonopathies) and the analysis of their genes in sequenced genomes (chaperonomics). Chaperonopathies are pathological conditions in which one type of chaperone is deficient due to a genetic or acquired defect that modifies the chaperone’s structure and/or makes the chaperone unavailable for functioning when needed. Experimental and clinical data show that chaperones and their genes can be used for treating various pathological conditions, thus justifying the development of chaperonotherapy. We discuss recent work showing that chaperonotherapy is on solid foundations: the data demonstrate that molecular chaperones counteract pathogenetic mechanisms in disease and during stress.

University of Maryland Biotechnology Institute (UMBI), Columbus Center, 701 E. Pratt Street, Baltimore, MD 21202, USA

Corresponding Author InformationCorresponding author. Fax: +1 410 234 8896.

PII: S0014-5793(07)00420-6

doi:10.1016/j.febslet.2007.04.030


View previous. 15 of 25 View next.